The c.4912G>A (p.V1638M) alteration is located in exon 12 (coding exon 9) of the MAP2 gene. This alteration results from a G to A substitution at nucleotide position 4912, causing the valine (V) at amino acid position 1638 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
ClinVar Genomic variation as it relates to human health
NM_001375505.1(MAP2):c.4912G>A (p.Val1638Met)
Germline
Classification
Help
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
(1)
Help
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
Uncertain significance
1
criteria provided, single submitter
Somatic
No data submitted for somatic clinical impact
Somatic
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_001375505.1(MAP2):c.4912G>A (p.Val1638Met)
Variation ID: 3122774 Accession: VCV003122774.1
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 2q34 2: 209710093 (GRCh38) [ NCBI UCSC ] 2: 210574817 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline May 1, 2024 May 1, 2024 Nov 7, 2023 - HGVS
-
... more HGVS ... less HGVSNucleotide Protein Molecular
consequenceNM_001375505.1:c.4912G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_001362434.1:p.Val1638Met missense NM_001039538.2:c.1015G>A NP_001034627.1:p.Val339Met missense NM_001363910.2:c.4900G>A NP_001350839.1:p.Val1634Met missense NM_001363911.2:c.4900G>A NP_001350840.1:p.Val1634Met missense NM_001363913.2:c.844G>A NP_001350842.1:p.Val282Met missense NM_001375474.1:c.1015G>A NP_001362403.1:p.Val339Met missense NM_001375493.1:c.844G>A NP_001362422.1:p.Val282Met missense NM_001375494.1:c.844G>A NP_001362423.1:p.Val282Met missense NM_001375495.1:c.1186G>A NP_001362424.1:p.Val396Met missense NM_001375496.1:c.1012G>A NP_001362425.1:p.Val338Met missense NM_001375497.1:c.841G>A NP_001362426.1:p.Val281Met missense NM_001375498.1:c.1180G>A NP_001362427.1:p.Val394Met missense NM_001375499.1:c.844G>A NP_001362428.1:p.Val282Met missense NM_001375500.1:c.4900G>A NP_001362429.1:p.Val1634Met missense NM_001375501.1:c.5158G>A NP_001362430.1:p.Val1720Met missense NM_001375502.1:c.4909G>A NP_001362431.1:p.Val1637Met missense NM_001375503.1:c.5140G>A NP_001362432.1:p.Val1714Met missense NM_001375504.1:c.5083G>A NP_001362433.1:p.Val1695Met missense NM_001375506.1:c.4909G>A NP_001362435.1:p.Val1637Met missense NM_001375507.1:c.4897G>A NP_001362436.1:p.Val1633Met missense NM_001375508.1:c.844G>A NP_001362437.1:p.Val282Met missense NM_001375509.1:c.1069G>A NP_001362438.1:p.Val357Met missense NM_001375510.1:c.1186G>A NP_001362439.1:p.Val396Met missense NM_001375526.1:c.4912G>A NP_001362455.1:p.Val1638Met missense NM_001375527.1:c.4909G>A NP_001362456.1:p.Val1637Met missense NM_001375528.1:c.4900G>A NP_001362457.1:p.Val1634Met missense NM_001375529.1:c.841G>A NP_001362458.1:p.Val281Met missense NM_001375530.1:c.841G>A NP_001362459.1:p.Val281Met missense NM_001375531.1:c.5155G>A NP_001362460.1:p.Val1719Met missense NM_001375532.1:c.841G>A NP_001362461.1:p.Val281Met missense NM_001375533.1:c.841G>A NP_001362462.1:p.Val281Met missense NM_001375534.1:c.4912G>A NP_001362463.1:p.Val1638Met missense NM_001375535.1:c.1087G>A NP_001362464.1:p.Val363Met missense NM_001375536.1:c.1186G>A NP_001362465.1:p.Val396Met missense NM_001375537.1:c.5158G>A NP_001362466.1:p.Val1720Met missense NM_001375538.1:c.1183G>A NP_001362467.1:p.Val395Met missense NM_001375539.1:c.5146G>A NP_001362468.1:p.Val1716Met missense NM_001375540.1:c.1180G>A NP_001362469.1:p.Val394Met missense NM_001375541.1:c.979G>A NP_001362470.1:p.Val327Met missense NM_001375542.1:c.838G>A NP_001362471.1:p.Val280Met missense NM_001375543.1:c.4909G>A NP_001362472.1:p.Val1637Met missense NM_001375544.1:c.4909G>A NP_001362473.1:p.Val1637Met missense NM_001375545.1:c.4897G>A NP_001362474.1:p.Val1633Met missense NM_001375546.1:c.4897G>A NP_001362475.1:p.Val1633Met missense NM_001375548.1:c.4897G>A NP_001362477.1:p.Val1633Met missense NM_001375551.1:c.4438G>A NP_001362480.1:p.Val1480Met missense NM_001375552.1:c.4438G>A NP_001362481.1:p.Val1480Met missense NM_001375553.1:c.715G>A NP_001362482.1:p.Val239Met missense NM_001375554.1:c.715G>A NP_001362483.1:p.Val239Met missense NM_001375555.1:c.4438G>A NP_001362484.1:p.Val1480Met missense NM_001375556.1:c.4438G>A NP_001362485.1:p.Val1480Met missense NM_001375557.1:c.4438G>A NP_001362486.1:p.Val1480Met missense NM_001375558.1:c.4435G>A NP_001362487.1:p.Val1479Met missense NM_001375559.1:c.4435G>A NP_001362488.1:p.Val1479Met missense NM_001375583.1:c.844G>A NP_001362512.1:p.Val282Met missense NM_002374.4:c.4912G>A NP_002365.3:p.Val1638Met missense NM_031845.3:c.844G>A NP_114033.2:p.Val282Met missense NM_031847.3:c.844G>A NP_114035.2:p.Val282Met missense NR_164693.1:n.1295G>A NR_164694.1:n.747G>A non-coding transcript variant NR_164695.1:n.765G>A non-coding transcript variant NR_164696.1:n.762G>A non-coding transcript variant NR_164697.1:n.765G>A non-coding transcript variant NR_164698.1:n.936G>A non-coding transcript variant NR_164699.1:n.703G>A non-coding transcript variant NC_000002.12:g.209710093G>A NC_000002.11:g.210574817G>A NG_052836.1:g.291047G>A - Protein change
- V1637M, V1695M, V1716M, V280M, V281M, V282M, V338M, V363M, V396M, V1633M, V1720M, V339M, V395M, V1480M, V1719M, V357M, V394M, V1479M, V1634M, V1638M, V1714M, V239M, V327M
- Other names
- -
- Canonical SPDI
- NC_000002.12:209710092:G:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
| Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
|---|---|---|---|---|---|---|
| HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
| MAP2 | - | - |
GRCh38 GRCh37 |
120 | 146 | |
Conditions - Germline
| Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
|---|---|---|---|---|
| Uncertain significance (1) |
criteria provided, single submitter
|
Nov 7, 2023 | RCV004416162.1 |
Submissions - Germline
| Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
|---|---|---|---|---|---|
|
Uncertain significance
(Nov 07, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
not specified
Affected status: unknown
Allele origin:
germline
|
Ambry Genetics
Accession: SCV004900345.1
First in ClinVar: May 01, 2024 Last updated: May 01, 2024 |
Comment:
The c.4912G>A (p.V1638M) alteration is located in exon 12 (coding exon 9) of the MAP2 gene. This alteration results from a G to A substitution … (more)
The c.4912G>A (p.V1638M) alteration is located in exon 12 (coding exon 9) of the MAP2 gene. This alteration results from a G to A substitution at nucleotide position 4912, causing the valine (V) at amino acid position 1638 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. (less)
|
Comment:
Germline Functional Evidence
| There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Comment:
The c.4912G>A (p.V1638M) alteration is located in exon 12 (coding exon 9) of the MAP2 gene. This alteration results from a G to A substitution at nucleotide position 4912, causing the valine (V) at amino acid position 1638 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Citations for germline classification of this variant
Help| There are no citations for germline classification of this variant in ClinVar. If you know of citations for this variation, please consider submitting that information to ClinVar. |
Text-mined citations for this variant ...
HelpRecord last updated May 08, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.